United Capital Financial Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,414
Closed -$636K 1678
2026
Q1
$636K Buy
+8,414
New +$633K ﹤0.01% 953
2025
Q1
Sell
-3,190
Closed -$230K 1087
2024
Q4
$230K Sell
3,190
-545
-15% -$42.6K ﹤0.01% 976
2024
Q3
$304K Buy
3,735
+186
+5% +$14.9K ﹤0.01% 866
2024
Q2
$264K Buy
3,549
+27
+0.8% +$2.02K ﹤0.01% 896
2024
Q1
$275K Sell
3,522
-543
-13% -$40.4K ﹤0.01% 909
2023
Q4
$290K Buy
+4,065
New +$283K ﹤0.01% 883
2018
Q2
Sell
-6,395
Closed -$239K 1333
2018
Q1
$239K Buy
6,395
+1,638
+34% +$66.2K ﹤0.01% 1177
2017
Q4
$206K Buy
+4,757
New +$190K ﹤0.01% 1234

Other funds holding HOLX

United Capital Financial Advisors's HOLX Position: Q2 2026 in Review

United Capital Financial Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8,414 shares — an estimated $636K sold.

United Capital Financial Advisors first reported a position in HOLX in Q4 2017 and held it in 8 quarters. The position peaked at $636K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • United Capital Financial Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • United Capital Financial Advisors sold 8,414 Hologic shares in Q2 2026, an estimated $636K.
  • United Capital Financial Advisors first reported a position in Hologic in Q4 2017 and held it in 8 quarters.
  • United Capital Financial Advisors's Hologic position peaked at $636K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.